Author Correction: Oral immunotherapy combined with omalizumab for high-risk cow's milk allergy: a randomized controlled trial

Masaya Takahashi; Kazuhiko Soejima; Shoichiro Taniuchi; Yasuko Hatano; Sohsaku Yamanouchi; Hideki Ishikawa; Makoto Irahara; Youhei Sasaki; Hiroshi Kido; Kazunari Kaneko

doi:10.1038/s41598-018-30919-3

Author Correction: Oral immunotherapy combined with omalizumab for high-risk cow's milk allergy: a randomized controlled trial

Sci Rep. 2018 Aug 21;8(1):12812. doi: 10.1038/s41598-018-30919-3.

Authors

Affiliations

¹ Department of Pediatrics, Kansai Medical University, Osaka, 573-1191, Japan.
² Department of Pediatrics, Kansai Medical University, Osaka, 573-1191, Japan. [email protected].
³ Department of Pediatrics, Takatsuki General Hospital, Osaka, 569-1192, Japan. [email protected].
⁴ Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
⁵ Department of Pediatrics, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, 770-8501, Japan.
⁶ Division of Enzyme Chemistry, Institute for Enzyme Research, Tokushima University, Tokushima, 770-8501, Japan.

Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

Publication types

Published Erratum